ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 143093 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 143093; 2) Community: the network communities that were significantly associated with the response to NSC 143093; 3) Molecule: the relationships between components within communities and NSC 143093; 4) MDR: the compounds that were significantly associated with the NSC 143093.

NSC Compound Enrichment Correlation
NSC 638309 Null 0.0129421834592789 0.3178016
NSC 646848 Bengamide H 0.0129421834592789 0.39016589
NSC 656925 Null 0.0129421834592789 0.28724242
NSC 674071 Null 0.0129421834592789 -0.094567177
NSC 692655 D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate 0.0129421834592789 0.15377007
NSC 693622 Null 0.0129421834592789 0.20657777
NSC 694493 9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(3-pyridinyl)- 0.0129421834592789 0.27342186
NSC 701555 2,3-Dihydro-1,2-syn-3-[phenylseleno]brefeldin A 0.0129421834592789 -0.19540892
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.0129421834592789 0.46384281
NSC 708244 Indolo[3,2-d]benzazepin-6(5H)-one, 9-cyano-2,3-dimethoxy-~7,12-dihydro- 0.0129421834592789 0.33309281
Total:152  Current:56    [First] [Prev] [Next] [Last]